Evaluating immune cell abundance across hepatocellular carcinoma disease stages I-III: Findings from TCGA analysis. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers ...
aDepartment of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China bDepartment of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China ...
Current prognostic methods, such as the 7th edition of AJCC staging, have limitations. This study aims to construct and validate a comprehensive nomogram integrating multiple clinicopathological ...
1The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York. 2Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback